Articles, App Notes, Case Studies, & White Papers

1. Elastomer Plungers With Barrier Film For COVID-19 Vaccines

   Minimize the risks of accelerated drug development processes and the potential use of new vaccine platform technologies with the use of an elastomer plunger laminated with FluroTec™ barrier film.

2. Microphysiological Systems: Closing The Gap Between Models And Medicine 9/2/2025

   Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.

3. Off-The-Shelf Vs. Novel Devices: Selecting A Drug Delivery System 4/19/2022

   Whether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.

4. Developing An Effective Lipid Nanoparticle Formulation Process For Small Molecule And Biologicals Delivery 3/1/2022

   Lipid nanoparticles (LNPs) are a versatile formulation technology used by drug development teams to deliver a variety of small/large molecules, peptides, and biologicals.

5. NMR And Mass Spectrometry In Pharmaceutical Development 10/26/2020

   Together, nuclear magnetic resonance (NMR) and MS analysis can definitively identify reference standards, active pharmaceutical ingredients (APIs), or final drug product composition.

6. Closing The Care Gap: Clinician Assistive Technologies 9/1/2025

   This technology addresses workforce shortages and growing medical complexity by helping healthcare providers manage rising demands, improve efficiency, reduce errors, and extend care access.

7. How DFM Promotes Scalability, Repeatability, And Profitability 6/28/2024

   Find out why it is critical that OEMs see and understand the benefits of taking time to build a mold or create automation more robustly to achieve long-term savings and higher annual production.

8. The Largest LOE Event In US Pharma History

   Ahead of the first biosimilar Humira product set to launch in 365 days, this article provides a comprehensive run-down of where biosimilar sponsors stand and the key issues ahead of market formation.

9. 2R Vials And Deep Cold Storage - Determining Mechanical & CCI Performance 8/27/2024

   Review the implications of this study on the storage of sensitive molecules that require deep-cold storage and learn how 2R Fina glass vials are poised to enhance cold storage practices.

10. Early Decisions To De-Risk The Transition To Combination Products

    The injectable product development landscape is changing, and the pressure to accelerate timelines remains constant. What can you do to overcome all the uncertainty and risk?